Drug

Who makes rifaximin?

3 companies list rifaximin as a human prescription drug, including under the names XIFAXAN. Forms: tablet. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing rifaximin

CompanyFormsApplicationNDCsRegistered sites
Salix Pharmaceuticals, Inc.tabletNDANDA02136120
Cardinal Health 418, Inc.United StatestabletNDANDA021361134
International Medication Systems, Ltd.United StatestabletNDANDA02136113

Bulk ingredient listings

Orange Book patents

15 unexpired patents list rifaximin as the active ingredient, expiring between Sept 2027 and Oct 2029. Application holder: SALIX PHARMACEUTICALS INC.

Enquiry

Common questions

Who makes rifaximin?
3 companies list rifaximin as a human prescription drug in the openFDA NDC Directory, led by Salix Pharmaceuticals, Inc., Cardinal Health 418, Inc., International Medication Systems, Ltd.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies rifaximin active ingredient?
15 companies list rifaximin as a bulk ingredient, including Olon USA LLC, Granules Pharmaceuticals Inc., MSN Laboratories Private Limited,, ALFASIGMA SPA.